A physiologically based pharmacokinetic (PBPK) model describing the kinetics of a commercial mixture α-, β-, and γ-hexabromocyclododecane exposure in mice. - Emond C; DeVito MJ; Birnbaum LS (Archives of toxicology, 2025)